Market Cap 169.26M
Revenue (ttm) 0.00
Net Income (ttm) -59.52M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 320,100
Avg Vol 365,484
Day's Range N/A - N/A
Shares Out 40.40M
Stochastic %K 73%
Beta 0.28
Analysts Strong Sell
Price Target $21.00

Company Profile

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in B...

Industry: Biotechnology
Sector: Healthcare
Phone: 720-307-2892
Address:
6707 Winchester Circle, Suite 400, Boulder, United States
outlawinvestor1
outlawinvestor1 May. 15 at 11:48 AM
$OKUR down 16.5%. early preclinical programs with catalyst vacuum until 2h '27 / 1h '28 may keep this below cash. i'm still bullish at these levels and will cost average down. fdmc: $185M ($3.50/sh) cash: $192M cash/fds: $3.62/sh
0 · Reply
Lukey63
Lukey63 May. 6 at 6:32 PM
$OKUR Back under cash and TBV, at least a 3 year runway, well funded. I’m considering adding.
1 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 2:11 AM
0 · Reply
bkfViking123
bkfViking123 Apr. 28 at 2:23 PM
$OKUR news highs ... holding the bottom
0 · Reply
bkfViking123
bkfViking123 Apr. 23 at 12:38 PM
$OKUR ,,, news any time
0 · Reply
Hearts_And_Pikes
Hearts_And_Pikes Apr. 17 at 5:14 PM
$OKUR on a breakout from ascending resistance april 2025-2026. Love it long term; but might be a place to take profits.
0 · Reply
outlawinvestor1
outlawinvestor1 Apr. 2 at 5:32 PM
$OKUR great trade so far. let's see if i can keep going. before we get oki-345/355 data.
0 · Reply
HedgedMyFeelings
HedgedMyFeelings Mar. 30 at 2:56 PM
$OKUR is this over?
1 · Reply
WycklyTrader
WycklyTrader Mar. 30 at 4:17 AM
Momo Watch: $ARTL $ PLYX $OKUR. DCB Watch: $RCKT $SLS $ADMA.
0 · Reply
MrBruceWayne
MrBruceWayne Mar. 29 at 2:10 PM
🚨💎 BUY ALERT$OKUR
0 · Reply
Latest News on OKUR
OnKure Therapeutics Transcript: AGM 2026

Jun 3, 2026, 9:00 AM EDT - 5 days ago

OnKure Therapeutics Transcript: AGM 2026


OnKure Therapeutics Quarterly report: Q1 2026

May 5, 2026, 7:00 AM EDT - 4 weeks ago

OnKure Therapeutics Quarterly report: Q1 2026


OnKure Therapeutics Earnings release: Q1 2026

May 5, 2026, 7:00 AM EDT - 4 weeks ago

OnKure Therapeutics Earnings release: Q1 2026


OnKure Therapeutics Registration statement: Registration filing

Apr 24, 2026, 8:00 AM EDT - 6 weeks ago

OnKure Therapeutics Registration statement: Registration filing


OnKure Therapeutics Slides: Corporate presentation

Apr 24, 2026, 7:00 AM EDT - 6 weeks ago

OnKure Therapeutics Slides: Corporate presentation


OnKure Therapeutics Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 6 weeks ago

OnKure Therapeutics Proxy statement: Proxy filing


OnKure Therapeutics Proxy statement: Proxy filing

Apr 21, 2026, 7:00 AM EDT - 6 weeks ago

OnKure Therapeutics Proxy statement: Proxy filing


OnKure Therapeutics reports Q4 EPS (99c), consensus ($1.15)

2026-03-12T20:32:29.000Z - 3 months ago

OnKure Therapeutics reports Q4 EPS (99c), consensus ($1.15)


OnKure Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 4:00 PM EDT - 3 months ago

OnKure Therapeutics Earnings release: Q4 2025


OnKure Therapeutics files $200M mixed securities shelf

2025-11-06T22:10:20.000Z - 7 months ago

OnKure Therapeutics files $200M mixed securities shelf


OnKure Therapeutics reports Q3 EPS ($1.09), consensus ($1.20)

2025-11-06T21:52:07.000Z - 7 months ago

OnKure Therapeutics reports Q3 EPS ($1.09), consensus ($1.20)


OnKure Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 7 months ago

OnKure Therapeutics Earnings release: Q3 2025


OnKure Therapeutics Slides: Investor Presentation

Nov 5, 2025, 6:00 PM EST - 7 months ago

OnKure Therapeutics Slides: Investor Presentation


OnKure Therapeutics reports Q2 EPS ($1.14), consensus ($1.25)

2025-08-12T20:35:30.000Z - 10 months ago

OnKure Therapeutics reports Q2 EPS ($1.14), consensus ($1.25)


OnKure Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 10 months ago

OnKure Therapeutics Quarterly report: Q2 2025


OnKure Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 10 months ago

OnKure Therapeutics Earnings release: Q2 2025


OnKure Therapeutics Slides: Investor Presentation

Jun 1, 2025, 9:00 AM EDT - 1 year ago

OnKure Therapeutics Slides: Investor Presentation


OnKure Therapeutics Transcript: AGM 2025

May 27, 2025, 9:00 AM EDT - 1 year ago

OnKure Therapeutics Transcript: AGM 2025


OnKure Therapeutics sees cash runway into 4Q26

2025-05-06T11:37:12.000Z - 1 year ago

OnKure Therapeutics sees cash runway into 4Q26


OnKure Therapeutics Quarterly report: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

OnKure Therapeutics Quarterly report: Q1 2025


OnKure Therapeutics Earnings release: Q1 2025

May 6, 2025, 7:00 AM EDT - 1 year ago

OnKure Therapeutics Earnings release: Q1 2025


OnKure Therapeutics Annual report: Q4 2024

Mar 11, 2025, 8:00 AM EDT - 1 year ago

OnKure Therapeutics Annual report: Q4 2024


OnKure Therapeutics Earnings release: Q4 2024

Mar 11, 2025, 8:00 AM EDT - 1 year ago

OnKure Therapeutics Earnings release: Q4 2024


OnKure Therapeutics reports Q4 EPS ($1.37), consensus (86c)

2025-03-11T00:50:09.000Z - 1 year ago

OnKure Therapeutics reports Q4 EPS ($1.37), consensus (86c)


OnKure Therapeutics Slides: Corporate Presentation

Mar 9, 2025, 7:00 PM EDT - 1 year ago

OnKure Therapeutics Slides: Corporate Presentation


OnKure Therapeutics initiated with a Buy at JonesResearch

2025-01-28T21:20:22.000Z - 1 year ago

OnKure Therapeutics initiated with a Buy at JonesResearch

LLY


OnKure Announces New Date for Upcoming Investor Call

Nov 25, 2024, 5:31 PM EST - 1 year ago

OnKure Announces New Date for Upcoming Investor Call


OnKure Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 6:00 PM EST - 1 year ago

OnKure Therapeutics Quarterly report: Q3 2024


outlawinvestor1
outlawinvestor1 May. 15 at 11:48 AM
$OKUR down 16.5%. early preclinical programs with catalyst vacuum until 2h '27 / 1h '28 may keep this below cash. i'm still bullish at these levels and will cost average down. fdmc: $185M ($3.50/sh) cash: $192M cash/fds: $3.62/sh
0 · Reply
Lukey63
Lukey63 May. 6 at 6:32 PM
$OKUR Back under cash and TBV, at least a 3 year runway, well funded. I’m considering adding.
1 · Reply
SuperGreenToday
SuperGreenToday May. 1 at 2:11 AM
0 · Reply
bkfViking123
bkfViking123 Apr. 28 at 2:23 PM
$OKUR news highs ... holding the bottom
0 · Reply
bkfViking123
bkfViking123 Apr. 23 at 12:38 PM
$OKUR ,,, news any time
0 · Reply
Hearts_And_Pikes
Hearts_And_Pikes Apr. 17 at 5:14 PM
$OKUR on a breakout from ascending resistance april 2025-2026. Love it long term; but might be a place to take profits.
0 · Reply
outlawinvestor1
outlawinvestor1 Apr. 2 at 5:32 PM
$OKUR great trade so far. let's see if i can keep going. before we get oki-345/355 data.
0 · Reply
HedgedMyFeelings
HedgedMyFeelings Mar. 30 at 2:56 PM
$OKUR is this over?
1 · Reply
WycklyTrader
WycklyTrader Mar. 30 at 4:17 AM
Momo Watch: $ARTL $ PLYX $OKUR. DCB Watch: $RCKT $SLS $ADMA.
0 · Reply
MrBruceWayne
MrBruceWayne Mar. 29 at 2:10 PM
🚨💎 BUY ALERT$OKUR
0 · Reply
SamuraiX7
SamuraiX7 Mar. 27 at 1:08 PM
$OKUR agree, it’s oversubscribed and private placement is way more than market cap + 2 big strong nstitutional funds backing 😌
0 · Reply
BearTamerTrading
BearTamerTrading Mar. 27 at 12:44 PM
🚨 $OKUR — READ THIS BEFORE YOU TRADE 🚨 Everyone is calling this dilution… but let’s be precise. 👉 YES — $150M PIPE announced 👉 NO — real selling pressure has NOT hit yet That move to $7.40 → dump was the market pricing in future dilution But those shares: ❌ NOT tradable yet ❌ Cannot be dumped yet ⸻ 🧠 Timeline: 1️⃣ Deal closes (1–3 days) 2️⃣ S-1 filed 3️⃣ 🚨 EFFECT = real dilution hits ⏱️ Typically 2–6 weeks after deal closes for those shares to start hitting the market bit by bit. ⸻ 📊 What this means: Now: ✅ Volatility ✅ Bounce setups ❌ Not a hold Later: 💣 Second wave when EFFECT hits ⸻ 🎯 Game plan: Trade it, don’t marry it. Watch S-1 → EFFECT 👉 That’s when everything changes
1 · Reply
outlawinvestor1
outlawinvestor1 Mar. 27 at 12:34 PM
$OKUR ok! i nibbled some shares below $4 in pm. let's see where these preclinical pan-mutant selective assets go. only problem is they won't hit the clinic until next year. neutral at this stage until i see more data for oki-345 and oki-355, but i respect the diligence performed by the set of new investors.
0 · Reply
Mapago
Mapago Mar. 27 at 12:33 PM
$OKUR OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
0 · Reply
SamuraiX7
SamuraiX7 Mar. 27 at 12:18 PM
$OKUR buying here
0 · Reply
leon_dedrick
leon_dedrick Mar. 27 at 12:15 PM
$OKUR Those shares are locked up and not being sold today.....so this selling pressure isnt coming from the company
0 · Reply
DaSqueeza
DaSqueeza Mar. 27 at 12:15 PM
$OKUR wow such a nice move
0 · Reply
leon_dedrick
leon_dedrick Mar. 27 at 12:12 PM
$OKUR I've seen these pull back to the issue price, then take off and run, so this movement doesn't mean anything right now..... Give it time to play out
0 · Reply
leon_dedrick
leon_dedrick Mar. 27 at 12:11 PM
$OKUR Issuance of 26,713,636 common shares and 9,430,959 pre‑funded warrants 4.15 per share Securities not registered for public resale; resale restrictions apply Company not pursuing further independent development of OKI‑219 now
0 · Reply
PharmaExpert
PharmaExpert Mar. 27 at 12:09 PM
$OKUR added!🔥 https://www.stocktitan.net/news/OKUR/on-kure-therapeutics-announces-oversubscribed-150-million-private-tcaj33ml7l8x.html
0 · Reply